Making a statement within the scope of Cancer Week, Oncology Specialist Prof.Dr. Serdar Turhal recommended that smokers should have lung tomography, women should have mammography, and all individuals should have colonoscopy.
Cancer Disease Statistics
Cancer, which affects millions of people every year around the world, is a disease that can be controlled with early diagnosis more than once. Underlining that apart from the annual medical check-up for early diagnosis, large intestine examinations such as mammography for women, lung tomography for smokers and colonoscopy for all individuals are valuable, Oncology Specialist Prof. Dr. Serdar Turhal said, “Very valuable achievements have been achieved in the treatment of this disease, especially in the last 10 years, and long-term control of the disease has been possible with drugs that work by affecting the immune system of the patient. Our success in cancer treatment will increase in the coming years, and many cancer patients, even cancer patients who have metastasized, that is, cancer patients whose disease has spread to other parts of the body, will be able to achieve long-term life chances, like early stage cancer patients. Stating that the 2022 annual cancer statistics are published in the United States, Turhal said, “According to these statistics, prostate cancer is the most common in men in the United States. Lung cancer comes second and colon cancer comes third. Breast cancer is the most common cancer in women, followed by lung cancer in the second place, and cancer of the large intestine and rectum in the third place.
Lung Cancer Accounts for 20 out of 100 Survivors
“Survey Results Should Be Reflected on Promotion Agreements”
Underlining that lung cancer accounts for 20 out of every 100 deaths in both women and men, Prof. Dr. Serdar Turhal said, “Prostate cancer accounts for 10 percent of deaths in men and 15 percent of breast cancer deaths in women. Cancer of the large intestine and rectum has a death rate of less than 10 percent in both men and women. Pancreatic cancer is the next most common cause of death in men and women. The death rate is 8 percent of all cancers. Liver and biliary tract cancers in men and ovarian cancers in women come next; Their death rates are similar to each other and are around 5 percent,” he said.
Success in Cancer Treatment Increases Every YearMost Valuable Risk Factor Age
Reminding that age is the most valuable risk factor in cancer, Medical Oncology Specialist Prof. Dr. Serdar Turhal said, “As you get older, the probability of getting cancer increases. Apart from age, smoking and family history of cancer are among the most valuable risk factors. Various chemicals, such as asbestos, are also a risk factor for cancer. Ultraviolet light from the sun is also one of the factors that increase the risk of cancer.
There Are Valuable Studies on Diagnosis
Sharing his intentions on what developments will happen in cancer treatment in the next few years, Medical Oncology Specialist Prof. Dr. Serdar Turhal said, “First of all, I can talk about innovations in diagnosis. This section has probably witnessed one of the most exciting developments this year, as the new generation sequencing assays that we have used after the diagnosis of cancer patients have become available for screening healthy individuals as of this year. With these formulas, it is possible to detect DNA fragments related to cancer cells circulating in the body and to start attempts to make that diagnosis absolute.”
New Treatments in Cancer Treatment on the Agenda
Stating that the development of drugs that started in the past years and that detect different mutations on cancer cells and stop them from dividing through mutations, continues at full speed, and that more drugs will have a therapeutic role in different cancer types in the coming years. Dr. Serdar Turhal said, “In addition to these, intravenous immunotherapy drugs that work on the immune system, drugs that emit radiation by intravenous administration, and innovations in radiotherapy devices seem to be available to more people in the coming years. Many studies continue on the use of mRNA vaccines in the treatment of cancer, and these include pancreatic cancer, colon cancer and melanoma. The use of these vaccines together with the currently used scientific treatments is also a topic of discussion, but these vaccines have not been approved for use in sick individuals, except for clinical trials. In this process, I hope that faster progress will be made in this area as well.” (BSHA-Science and Health News Agency)
